ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Garrett L. Walsh
Kelly M. Willis
Rose S. Wong
Jonathan C. Nesbitt
Joe B. Putnam, Jr
Jack A. Roth
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, G. L.
Right arrow Articles by Roth, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, G. L.
Right arrow Articles by Roth, J. A.
Related Collections
Right arrowRelated Articles

Ann Thorac Surg 1995;60:1563-1570
© 1995 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Is Follow-up of Lung Cancer Patients After Resection Medically Indicated and Cost-Effective?

Garrett L. Walsh, MD, Maeve O'Connor, Kelly M. Willis, MPH, Mira Milas, MD, Rose S. Wong, MD, Jonathan C. Nesbitt, MD, Joe B. Putnam, Jr, MD, J. Jack Lee, PhD, Jack A. Roth, MD

Departments of Thoracic and Cardiovascular Surgery and Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Background. There are no guidelines for the appropriate follow-up of patients after pulmonary resection for lung cancer.

Methods. Three-hundred fifty-eight consecutive patients who had undergone complete resections of non-small cell lung cancer between 1987 and 1991 were evaluated for tumor recurrence and development of second primary tumors. Recurrences were categorized by site (local or distant), mode of presentation (symptomatic or asymptomatic), treatment given (curative intent or palliative), and duration of overall survival.

Results. Recurrences developed in 135 patients (local only, 32; local and distant, 13; and distant only, 90). Of these, 102 were symptomatic and 33 were asymptomatic (most diagnosed by screening chest roentgenogram). Forty patients received treatment with curative intent (operation or radiation therapy > 50 Gy) and 95 were treated palliatively. The median survival duration from time of recurrence was 8.0 months for symptomatic patients and 16.6 months for asymptomatic patients (p = 0.008). Multivariate analysis shows that disease-free interval (greater than 12 months or less than or equal to 12 months) was the most important variable in predicting survival after recurrence and that mode of presentation, site of recurrence, initial stage, and histologic type did not significantly affect survival. New primary tumors developed in 35 patients.

Conclusions. Although detection of asymptomatic recurrences gives a lead time bias of 8 to 10 months, mode of treatment and overall survival duration are not greatly affected by this earlier detection. Disease-free interval appears to be the most important determinant of survival. Screening for asymptomatic recurrences in patients who have had lung cancer is unlikely to be cost-effective. Frequent follow-up and extensive radiologic evaluation of patients after operation for lung cancer are probably unnecessary.


Related Articles

The ``Cured'' Lung Cancer Patient: Is Follow-up by the Surgeon Worthwhile?
Clement A. Hiebert
Ann. Thorac. Surg. 1995 60: 1557-1558. [Extract] [Full Text]

Discussion
Ann. Thorac. Surg. 1995 60: 1570-1572. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Nakagawa, N. Okumura, K. Ohata, H. Igai, T. Matsuoka, and K. Kameyama
Postrecurrence survival in patients with stage I non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 499 - 504.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Rubins, M. Unger, and G. L. Colice
Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 355S - 367S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Sugimura, F. C. Nichols, P. Yang, M. S. Allen, S. D. Cassivi, C. Deschamps, B. A. Williams, and P. C. Pairolero
Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection
Ann. Thorac. Surg., February 1, 2007; 83(2): 409 - 418.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. A. Williams, H. Sugimura, C. Endo, F. C. Nichols, S. D. Cassivi, M. S. Allen, P. C. Pairolero, C. Deschamps, and P. Yang
Predicting Postrecurrence Survival Among Completely Resected Nonsmall-Cell Lung Cancer Patients.
Ann. Thorac. Surg., March 1, 2006; 81(3): 1021 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Kent, P. Korn, J. L. Port, P. C. Lee, N. K. Altorki, and R. J. Korst
Cost Effectiveness of Chest Computed Tomography After Lung Cancer Resection: A Decision Analysis Model
Ann. Thorac. Surg., October 1, 2005; 80(4): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Battafarano, S. D. Force, B. F. Meyers, J. Bell, T. J. Guthrie, J. D. Cooper, and G. A. Patterson
Benefits of resection for metachronous lung cancer
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 836 - 842.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. K. Ferguson and A. G. Lehman
Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques
Ann. Thorac. Surg., December 1, 2003; 76(6): 1782 - 1788.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C.-H. Chiu, M.-S. Chern, M.-H. Wu, W.-H. Hsu, Y.-C. Wu, M.-H. Huang, and S.-C. Chang
Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary report
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1300 - 1305.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. L. Colice, J. Rubins, and M. Unger
Follow-up and Surveillance of the Lung Cancer Patient Following Curative-Intent Therapy
Chest, January 1, 2003; 123(1_suppl): 272S - 283S.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. P. Lamont, J. T. Kakuda, D. Smith, L. D. Wagman, and F. W. Grannis Jr
Systematic Postoperative Radiologic Follow-up in Patients With Non-Small Cell Lung Cancer for Detecting Second Primary Lung Cancer in Stage IA
Arch Surg, August 1, 2002; 137(8): 935 - 939.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. R. Benfield
Systematic Postoperative Radiologic Follow-up in Patients With Non-Small Cell Lung Cancer for Detecting Second Primary Lung Cancer in Stage IA--Invited Critique
Arch Surg, August 1, 2002; 137(8): 940 - 940.
[Full Text] [PDF]


Home page
Eur Respir JHome page
U. Egermann, K. Jaeggi, J.M. Habicht, A.P. Perruchoud, P. Dalquen, and M. Soler
Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients?
Eur. Respir. J., March 1, 2002; 19(3): 464 - 468.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Jeremic, Y. Shibamoto, L. Acimovic, N. Nikolic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic
Second Cancers Occurring in Patients With Early Stage Non-Small-Cell Lung Cancer Treated With Chest Radiation Therapy Alone
J. Clin. Oncol., February 15, 2001; 19(4): 1056 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Nguyen, S. Desai, A. Chen, T. S. Weiser, and D. S. Schrump
Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin
Ann. Thorac. Surg., December 1, 2000; 70(6): 1853 - 1860.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. B. Ponn
Lightning Can Strike Twice : Second Primary Lung Cancers
Chest, December 1, 2000; 118(6): 1526 - 1529.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. Westeel, D. Choma, F. Clement, M.-C. Woronoff-Lemsi, J.-F. Pugin, A. Dubiez, and A. Depierre
Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer
Ann. Thorac. Surg., October 1, 2000; 70(4): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Gilbert, K. R. Reid, M. Y. Lam, and D. Petsikas
Who should follow up lung cancer patients after operation?
Ann. Thorac. Surg., June 1, 2000; 69(6): 1696 - 1700.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. J. Downey
Follow-up of Patients With Completely Resected Lung Cancer
Chest, June 1, 1999; 115(6): 1487 - 1489.
[Full Text] [PDF]


Home page
ChestHome page
R. N. Younes, J. L. Gross, and D. Deheinzelin
Follow-up in Lung Cancer: How Often and for What Purpose?
Chest, June 1, 1999; 115(6): 1494 - 1499.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Yokoi, N. Kamiya, H. Matsuguma, S. Machida, T. Hirose, K. Mori, and K. Tominaga
Detection of Brain Metastasis in Potentially Operable Non-small Cell Lung Cancer: A Comparison of CT and MRI
Chest, March 1, 1999; 115(3): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. A. Hiebert
The ``Cured'' Lung Cancer Patient: Is Follow-up by the Surgeon Worthwhile?
Ann. Thorac. Surg., December 1, 1995; 60(6): 1557 - 1558.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.